semaglutide and gastric sleeve Bariatric Surgery Outperforms GLP-1s in Weight Loss Semaglutide versus placebo in individuals

Months 6-18: sustained response The SURMOUNT-5 trial ran for 72 weeks (about 18 months) and showed continued weight loss throughout the study period for most tirzepatide users

The rate of 0.25 mg/kg/h is maintained for 6 hours to assess for side effects before further dose increases up to a maximum rate of 1 mg/kg/h infused continuously for a maximum of 5 days

doi:10.1016/j.cmet.2026.03.011 6

The character of the nausea may change from occasional queasiness to a more persistent feeling, especially in the 24 to 48 hours following injection

Despus de suspender la semaglutida, el peso promedio individual se reduce en cerca de dos tercios (67%) del peso que se pierde durante el tratamiento al ao siguiente

She sent a follow-up email after every visit with a list of 3-5 exercises to do at home, together with a video for each one